6533b839fe1ef96bd12a6456
RESEARCH PRODUCT
Comparative expression of cyclooxygenase 2 and Ki67 in amelanotic and conventional oral melanomas
Bruno Augusto Benevenuto De AndradeJacks JorgeMacedo MrCiro Dantas SoaresOslei Paes De AlmeidaJuan Carlos Hernández-guerreroAdalberto Mosqueda-taylorRoman CarlosMário José Romañachsubject
Pathologymedicine.medical_specialtySkin NeoplasmsDigital analysisOral cavity03 medical and health sciences0302 clinical medicinemedicineHumansGeneral DentistryMouth neoplasmOral Medicine and Pathologybiologybusiness.industryResearchMelanomaMelanoma Amelanotic030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]StainingKi-67 AntigenOtorhinolaryngologyCyclooxygenase 2UNESCO::CIENCIAS MÉDICASbiology.proteinImmunohistochemistryMouth NeoplasmsSurgeryCyclooxygenasebusinessdescription
Background Oral melanomas have some histopathological resemblance with its cutaneous counterpart; however, an aggressive behavior is more common in tumors that occur in the oral cavity. Several markers have been suggested as indicative of tumoral progression and aggressiveness, such as cyclooxygenase 2 (COX-2) and Ki67. Material and Methods In this study, we have compared the expression of COX-2 and Ki67 in a series of amelanotic (n=7) and melanotic oral melanomas (n=22). The cases were selected from 4 pathology laboratories and submitted to the immunohistochemical (IHC) reactions. We analyzed the IHC staining based on a qualitative – using visual scores; and a computer-assisted method (quantitative) using scanned slides and software for digital analysis. Results COX-2 was expressed in all oral melanomas; however, its intensity was significantly higher in the amelanotic ones (P<0.001). Similarly, a high Ki67-positivity index was observed in the amelanotic than melanotic ones (P<0.001). Conclusions Based on these results, we suggest that amelanotic oral melanomas have marked pro-inflammatory and high-proliferative phenotype, justifying their more aggressive behavior compared with the melanotic ones. Key words:Oral melanoma, amelanotic tumor, cyclooxygenase 2, Ki67.
year | journal | country | edition | language |
---|---|---|---|---|
2020-05-01 |